These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 15560057)

  • 1. Use and interpretation of HCV diagnostic tests in the clinical setting.
    Gretch DR
    Clin Liver Dis; 1997 Nov; 1(3):543-57, vi. PubMed ID: 15560057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interpretation of hepatitis C virus serology: immunoblot and genome amplification].
    Maniez-Montreuil M; Dubois F
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():25s-30s. PubMed ID: 10919220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of viremia for cases of hepatitis C virus (HCV) infection using a third-generation anti-HCV enzyme immunoassay test.
    Huang WS; Lu SN; Wang JH; Lee CM; Tung HD; Chen TM; ChangChien CS
    Hepatogastroenterology; 2005; 52(63):893-6. PubMed ID: 15966227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative signal of anti-HCV by an automated assay predicts viremia in a population at high prevalence of hepatitis C virus infection.
    Bossi V; Galli C
    J Clin Virol; 2004 May; 30(1):45-9. PubMed ID: 15072753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays.
    Galel SA; Strong DM; Tegtmeier GE; Holland PV; Kuramoto IK; Kemper M; Pietrelli L; Gallarda J
    Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guideline for interpretation and report of the antibody to hepatitis C virus. Grupo de Desarrollo de la Guía ].
    Contreras AM; Ochoa-Jiménez RJ; Kershenobich D; Granados-García V; Conde-González CJ; Celis A; Pérez-Gómez HR; Ruelas-Hernández S; Romero-Flores P; Alcántar-Luna E; Sierra-García de Quevedo J; Ancona-Pisté O;
    Rev Invest Clin; 2012; 64(6 Pt 2):641-78. PubMed ID: 23593783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody testing and RT-PCR results in hepatitis C virus (HCV) infection: HCV-RNA detection in PBMC of plasma viremia-negative HCV-seropositive persons.
    Caudai C; Padula MG; Bastianoni I; Valensin PE; Shyamala V; Han J; Boggiano CA; Almi P
    Infection; 1998; 26(3):151-4. PubMed ID: 9646105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced detection of antibodies to hepatitis C virus by use of a third-generation recombinant immunoblot assay.
    Buffet C; Charnaux N; Laurent-Puig P; Chopineau S; Quichon JP; Briantais MJ; Dussaix E
    J Med Virol; 1994 Jul; 43(3):259-61. PubMed ID: 7523581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
    Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
    J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic tests for hepatitis C.
    Gretch DR
    Hepatology; 1997 Sep; 26(3 Suppl 1):43S-47S. PubMed ID: 9305663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.
    Alvarez M; Planelles D; Vila E; Montoro J; Franco E
    Vox Sang; 2004 May; 86(4):266-7. PubMed ID: 15144533
    [No Abstract]   [Full Text] [Related]  

  • 12. Anti-HCV RIBA/LiaTek reactivity and HCV genotype in EIA-negative patients with viremia.
    Brojer E; Kryczka W; Medyńska J; Grabarczyk P; Kubicka J; Głoskowska-Moraczewska Z; Loch T; Cianciara J; Juszczyk J; Bolewska B; Zupańska B
    J Med Virol; 1999 Dec; 59(4):451-5. PubMed ID: 10534725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of hepatitis C virus in Brazilian blood donors using a reverse transcriptase nested polymerase chain reaction: comparison with enzyme immunoassay and recombinant protein immunoblot assay.
    Gonçales NS; Costa FF; Vassallo J; Gonçales FL
    Rev Inst Med Trop Sao Paulo; 2000; 42(5):263-7. PubMed ID: 11058936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of branched DNA signal amplification for the detection of hepatitis C virus RNA.
    Alter HJ; Sanchez-Pescador R; Urdea MS; Wilber JC; Lagier RJ; Di Bisceglie AM; Shih JW; Neuwald PD
    J Viral Hepat; 1995; 2(3):121-32. PubMed ID: 7493306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
    Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
    Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications.
    Gretch DR; dela Rosa C; Carithers RL; Willson RA; Williams B; Corey L
    Ann Intern Med; 1995 Sep; 123(5):321-9. PubMed ID: 7542853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of hepatitis C virus (HCV) antibody test systems in relation to HCV-RNA detection in the diagnosis of HCV infection.
    Krarup HB; Jacobsen SE; Varming K; Drewes AM; Madsen PH
    Dan Med Bull; 1998 Feb; 45(1):89-91. PubMed ID: 9504268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Supplementary anti-hepatitis C virus (HCV) testing with 2nd and 3rd generation recombinant immunoblot assay and matrix applied to enzyme immunoassay positive sera and comparison with HCV-RNA detection.
    Engel PM; Dennin RH
    Zentralbl Bakteriol; 1998 Oct; 288(2):267-75. PubMed ID: 9809407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of the Signal-to-Cutoff Ratio in Automated Anti-HCV Chemiluminescent Immunoassays by Referring to the Nucleic Acid Amplification Test and the Recombinant Immunoblot Assay.
    Choi MS; Lee K; Hong YJ; Song EY; Kim DS; Song J
    Ann Lab Med; 2018 Sep; 38(5):466-472. PubMed ID: 29797818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.